> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bill Would End ‘Pay for Delay’
- URL: https://www.fdaweb.com/bill-would-end-pay-for-delay/
- Published: 2019-01-10T12:00:00.000Z
- Updated: 2026-09-15T00:53:39.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143130

Sens. **Chuck Grassley** (R-IA) and **Amy Klobuchar** (D-MN) have reintroduced their Preserve Access to Affordable Generics and Biosimilars Act to crack down on anti-competitive pay-for-delay drug deals in which branded companies pay their generic competitors not to compete as part of a patent settlement. The senators [say](https://www.klobuchar.senate.gov/public/index.cfm/news-releases?ID=9A1C02A7-1776-4663-8D5A-E3B8047C640F&ref=fdaweb.com) the legislation would stop the anti-competitive payoff agreements that keep more affordable generic and biosimilar equivalents off the market and ensure that consumers have access to the cost saving pharmaceuticals they need.